| Juan C. Mareque-Rivas was born and grew up in Santiago de Compostela (Galicia, Spain).
He received his undergraduate education at the University of Strathclyde (Glasgow) and Universidad de Santiago de Compostela,
where he conducted research projects in Physical Chemistry and Medicinal Inorganic Chemistry. He then undertook Ph.D. studies
(1995-1998) in Inorganic and Supramolecular Chemistry at the University of Missouri in St. Louis under the supervision of Prof.
After earning his Ph.D degree, he did two years of postdoctoral research in Bioinorganic Chemistry at the Massachusetts Institute of Technology in the laboratory of Prof. Stephen J. Lippard. He began his independent research career at the EaStCHEM School of Chemistry of the University of Edinburgh (2000-2010). In January 2011, he joined CiC biomaGUNE as IKERBASQUE Research Professor and Group Leader, where his research program focuses on finding new bio-inspired chemistry based on molecular recognition, cooperativity and self-assembly and how it can be implemented in the development of improved therapeutics/diagnosis and methodologies for bio-/chemosensing.
|Nina Gómez Blanco received her degree in Chemistry from the University of A Coruña (2005), where in 2010 she obtained also a PhD in inorganic chemistry. During her PhD she spent six months at the EaStCHEM School of Chemistry of the University of Edinburgh under the supervision of Prof. Juan Mareque.
After working as postdoctoral researcher at The Institute of Chemical Research of Catalonia (ICIQ) in the laboratory of Prof. P. van Leeuwen developing nanocatalysts, she joined the group of Prof. Juan Mareque at CIC biomaGUNE in CICbiomaGUNE.
Her current research interests are oriented towards the preparation and characterization of biofunctional hybrid organic-inorganic nanoparticles as bioactive agents for applications in molecular imaging and nanomedicine.
|Ane Ruiz de Angulo obtained her Biotechnology Degree from the Universitat Autònoma de Barcelona (Spain). During her Masters Degree in Biomedicine at the Universitat de Barcelona (UB), she worked on characterization of new therapies for fighting chemoresistance mechanisms in ovarian cancer.
Once she finished her work in UB, she spent three months undertaking work experience at the ‘Basic, Translational and Molecular Neurogenetics Research Unit’ (IGTP Institute, Barcelona).
Ane started her PhD at CICbiomaGUNE in November 2012. Her project is focused on developing new delivery systems with immunological activity in order to evaluate the in vitro and in vivo responses.
Ane's full CV can be found here
|Ana Isabel Bocanegra Gondan obtained her degree in Biotechnology at the Universidad Pablo de Olavide (Sevilla, Spain) in 2012. During her Masters degree in molecular genetics at the Universidad de Sevilla, she worked on the characterization of molecular mechanisms underlying the coordination between the processes of neuronal proliferation and differentiation at CABIMER under the supervision of Prof. Mario García Domínguez.
In June 2013, she joined Prof. Juan Mareque's group at CIC BiomaGUNE (San Sebastián, Spain) to start her PhD. Her project aims at developing nanoparticles decorated with TLR ligands for immunological therapy.
|Amaia Garaikoetxea Arguinzoniz obtained her BSc in Chemistry with Analytical Chemistry from the University of Strathclyde (2009) and a degree in Chemistry from the University of the Basque Country (2010). Afterwards, she continued her career working for the Analytical Chemistry department at the University of the Basque Country (UPV-EHU) as a researcher.
Once finished the work at the UPV-EHU she worked as a scientist assistant for the Environment Agency- National Laboratory Service at their laboratory in Exeter (Devon, United Kingdom) before joining Prof. Juan Mareque’s group at CIC biomaGUNE.
She has now started her PhD in the development of nanoparticle-activated platinum-based drugs for multifunctional imaging and targeted cancer treatment.
|Aintzane received her degree in Biochemistry from the Universidad de Navarra (2002), where in 2007 she obtained also a PhD degree in experimental immunology under the supervision of Dr. Pablo Sarobe. Her work was focused on the development of new vaccination strategies against Hepatitis C Virus (HCV). She did her postdoctoral research at National Institutes of Health (NIH) in Bethesda, USA, in the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) under the supervision of Barbara Rehermann. During this period she worked in the analysis of the implication of NK cells in the resolution of HCV in patients under the treatment of PEG-IFNα plus ribavirin. After working as postdoctoral researcher at NIH, she joined the group of Dr. Pablo Sarobe, where she worked as production manager in the clinical trial Nº EudraCT 2010-024043-32 titled “Phase I/II clinical trial of therapeutical vaccination of chronic Hepatitis C patients by the administration of NS3 coding adenoviral vector transduced autologous dendritic cells”, she was also responsible for the analysis of the immune response of patients enrolled in the clinical trial mentioned above. She has recently joined the group of Prof. Juan Mareque at CIC biomaGUNE.
Aintzane's publication list can be found here
|María Jesús García Granda obtained her Degree in Biology at the University of Oviedo (Spain). During her Master Degree at the University Complutense of Madrid (UCM), she worked on the analysis of cell behaviour on hydrogels and porous surfaces made of polystyrene. Once finished the Master Degree, she worked as a scientist advisor for GlaxoSmithKline Pharmaceuticals, before joining to CICbiomaGUNE.
Mª Jesús started her PhD at CICbiomaGUNE in January 2016. Her project aims the biofunctionalization of iron nanoparticles using monoclonal antibodies for improving the diagnosis and treatment of cancer and metastasis.
|Giordano Traini received both his Bachelor's and Master's degree in chemistry (2009-2014) at the University of Camerino, working in the laboratory of professor Carlo Santini on synthesis, purification and characterization of scorpionate ligands and their complexes. During his Master's studies he spent five months in Grenoble (France) at the European Synchrotron Radiation Facility improving the synthesis and testing the biological activity of bismuth nanoparticles, a project granted and financed by the COST STSM action 1205. Later, he joined the group of Theranostic Nanomedicine in CIC BiomaGUNE in June 2015 as a PhD student enrolled in ""TOLLerant", a project that focuses on the interaction of toll-like receptors with both small molecules and nanoparticles.
|Anja Bernecker worked on the study the molecular interactions of pathogens with cells of the immune system and the targeting of nanomaterials in cancer research.|
| Her work focused on the functionalization of nanoparticles for various immunological and medical-based uses.
|Abraha Habtemariam is a Senior Research Fellow in the group of Prof. P. J. Sadler at the University of Warwick (Coventry, UK). Thanks to a Ikerbasque Visiting Professor Fellowship, he spent a year ( May 2013 - May 2014) in the group working with Luca and Emmanuel on the synthesis of new photoactive metal complexes and their loading to nanomaterials. |
|His research focused on the integration of PET imaging agents with therapeutic properties into multifunctional nanoparticles to combine molecular imaging and therapy.|
|Patricia worked on the study of the immune system signals activated by pathogenic-mimetic nanostructures.
|Beatriz Macarena Cobaleda obtained her PhD in November 2015 developing modular multimodal iron oxide-based nanocarriers for image-guided dsRNA immunostimulation and platinum anticancer drug desing.|